FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/07/2017 |
3. Issuer Name and Ticker or Trading Symbol
KIMBERLY CLARK CORP [ KMB ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 31,345 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Restricted Share Units 07/31/2015 (w/dividends reinvested) | (1) | (1) | Common Stock | 2,252.9047 | $0.0000(2) | D | |
Stock Option (Right to Buy)(3) | (4) | 05/02/2022 | Common Stock | 12,098(5) | $75.2203(5) | D | |
Stock Option (Right to Buy)(3) | (4) | 05/01/2023 | Common Stock | 17,690(5) | $98.9241(5) | D | |
Stock Option (Right to Buy)(3) | (4) | 04/30/2024 | Common Stock | 15,115(5) | $107.5054(5) | D | |
Stock Option (Right to Buy)(3) | (4) | 04/29/2025 | Common Stock | 15,241 | $110.72 | D | |
Stock Option (Right to Buy)(3) | (4) | 05/03/2026 | Common Stock | 13,875 | $126.13 | D |
Explanation of Responses: |
1. The restricted share units will vest on July 31, 2018. |
2. Represents restricted share units payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's common stock. |
3. Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan. |
4. In general, no option may be exercised until one year after it has been granted; after the end of one year, it may be exercised as to 30 percent or less of the total shares subject to options, after the end of the second year, an additional 30 percent, and after the end of the third year, all options may be exercised. |
5. All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off. |
Remarks: |
agarwalpoa.txt |
/s/ Jeffrey S. McFall as attorney-in-fact for Achal Agarwal | 02/16/2017 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |